Sunday, February 13, 2011

MYMX Stock News Mymetics Vaccines for infectious diseases

Mymetics' Novel HIV Vaccine to Begin New NIH-Funded Study at University of California, Davis

Prof. Christopher J. Miller to Lead Proof-of-Concept Study on Innovative HIV Vaccine Aimed at Preventing Mucosal Transmission and Infection in Macaque Monkeys; Preclinical Trial Follows Previous Study Where Vaccine Provided Unprecedented 100% Protection


No comments:

Post a Comment